The vote comes after a special federal advisory committee met to debate the issue. A final say on the matter is expected from CDC Director Dro. Rochelle Walensky.
Last week, the U.S. Food and Drug Administration (FDA) authorized emergency use for kid doses, which are about one-third of the dose given to adolescents and adults. The vaccine is already approved for emergency use in children 12-15 years old.
Tuesday’s move means that as many as 28 million more children could be eligible for vaccinations as soon as this week.
Only Pfizer/BioNTech vaccines are available thus far for adolescents, and the Moderna and Johnson & Johnson Janssen vaccines are still being tested.
The Biden administration, awaiting a green light, has been assembling and shipping millions of COVID-19 shots for children.
“We are not waiting on the operations and logistics,” White House coronavirus coordinator Jeff Zients said Tuesday, assuring that the administration is “in great shape on supply.”
Zients said that the administration had started preparation after the FDA’s authorization. Workers at Pfizer and distribution centers then began to prepare and pack 15 million doses.
“More doses will be packed and shipped and delivered,” he added. “More and more vaccine will come on line as we ramp up.”
Walensky has also stressed that Pfizer/BioNTech clinical trials of the vaccine for children have found it to be highly effective in preventing serious disease with no severe side effects – though children are less likely to suffer severe COVID-19 infections.
“There has been a great deal of anticipation from parents,” Walensky said. “I encourage parents to ask questions.”
The Associated Press contributed to this report.